COVID-19

Having COVID-19 was associated with a small change in menstrual cycle length like that observed with COVID-19 vaccination, with changes resolving within the next cycle, researchers reported in Obstetrics & Gynecology.

Access to COVID-19 therapeutic drugs in U.S. counties decreased if the county had an increased population of Black individuals, according to a research letter published in JAMA Network Open.

Use of real-time mass spectrometry breath analysis that has been enhanced by artificial intelligence is a potential COVID-19 screening method, according to a presentation at the European Respiratory Society International Congress.

In 2022, more than one in 20 adults in the United States reported ever having long COVID, with women more likely than men to report lingering COVID-19 symptoms months after infection, a CDC survey found.

Paxlovid was associated with a significant reduction in 30-day hospitalization or death among previously uninfected patients with COVID-19 who were not hospitalized, researchers found.

The U.S. government is offering its fifth round of free at-home tests for COVID-19, with four tests per household available at COVIDTests.gov as of Monday, Sept. 25.

Adults hospitalized with COVID-19 were less likely to experience critical outcomes such as ICU admission, respiratory failure or death during later periods of the pandemic, researchers found.

Incidence rates for both type 1 and type 2 diabetes diagnoses increased among children and adolescents during the COVID-19 pandemic compared with 2016 to 2019, according to study findings published in JAMA Network Open.

Free at-home COVID-19 tests will be available for mail order again in the United States beginning on Monday, Sept. 25.

Relative risk for venous thromboembolism appeared high among patients with COVID-19 and cancer who received specific cancer treatments, according to study results published in JAMA Oncology.